Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
============================================================================================================================================

* Douglas G McNeel
* Jens C Eickhoff
* Ellen Wargowski
* Laura E Johnson
* Christos E Kyriakopoulos
* Hamid Emamekhoo
* Joshua M Lang
* Mary Jane Brennan
* Glenn Liu